Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Low RiskFDA Drug
Medications & Supplements/Over-the-Counter

A-S Medication Solutions LLC.: Cetirizine Hydrochloride Allergy Tablets Recalled for Mislabeled Tablet Count

Agency Publication Date: November 5, 2021
Share:
Sign in to monitor this recall

Summary

A-S Medication Solutions LLC has recalled 72 bottles of Cetirizine hydrochloride (10 mg), an allergy relief medication. The product was incorrectly relabeled as a 90-count bottle when it actually contains a manufacturer's box of only 30 tablets. This labeling error means consumers receive 60 fewer tablets than expected, which could cause an unexpected shortage of their medication. These bottles were distributed to locations in Florida, Indiana, Minnesota, and Wisconsin.

Risk

The product label indicates there are 90 tablets, but the packaging only contains 30 tablets. This discrepancy could lead to a patient running out of their allergy medication significantly sooner than anticipated, potentially causing a return of allergy symptoms.

What You Should Do

  1. Check your medication bottles for Cetirizine hydrochloride (10 mg) in 90-count containers with NDC 50090-5510-3 and Lot #: 1256330.
  2. Inspect the package to see if the contents match the label; affected units contain a 30-count manufacturer's box inside a container labeled for 90 tablets.
  3. Contact your healthcare provider or pharmacist for guidance if you have been using this medication and have less than the expected supply.
  4. Return any unused or mislabeled medication to the pharmacy or place of purchase for a refund.
  5. Contact A-S Medication Solutions LLC or your dispensing pharmacy for further instructions regarding the return of the product.
  6. For additional questions or to report adverse events, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

💰Full Refund

Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Cetirizine hydrochloride, 10 mg tablets (90-count bottle)
Model:
NDC: 50090-5510-3
Recall #: D-0096-2022
Lot Numbers:
1256330

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 88853
Status: Resolved
Manufacturer: A-S Medication Solutions LLC.
Sold By: Pharmacies; Healthcare providers
Manufactured In: United States
Units Affected: 72 bottles
Distributed To: Florida, Indiana, Minnesota, Wisconsin

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.